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Voltage-operated calcium channelIn this review we describe the present knowledge about store operated Ca2+ entry (SOCE) in neurons and the
proteins involved in this process: STIM, as well as Orai and TRP channels. We address the issue of whether
SOCE is used only to reﬁll Ca2+ in the ER orwhether Ca2+ that enters the neuronal cell during SOCE also performs
signaling functions. We collected the data indicating that SOCE and its components participate in the important
processes in neurons. This has implications for identifying new drug targets for the treatment of brain diseases.
Evidence indicates that in neurodegenerative diseases Ca2+ homeostasis and SOCE components become
dysregulated. Thus, different targets and strategies might be identiﬁed for the potential treatment of these
diseases. This article is part of a Special Issue entitled: 13th European symposium on calcium.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Calcium ions are a universal second messenger that regulates
various processes, such as proliferation, transcription, contraction,
exocytosis, apoptosis, the immune response, and neurotransmission
[1–4]. The concentration of Ca2+ is tightly regulated spatially and
temporally by multiple Ca2+ channel pumps, exchangers, and protein
buffers. At rest, intracellular Ca2+ levels remain within the range of
100–300 nM and increase upon cell activation. An increase in cytoplas-
mic Ca2+ concentration can occur by the inﬂux of Ca2+ ions through the
plasma membrane (PM) and/or their release from intracellular stores,
such as the endoplasmic reticulum (ER). This increase is usually in
the form of microdomains with Ca2+ concentrations in the range of
50–100 μM [5–7].
Synaptic transmission and neuronal plasticity are based on several
Ca2+-dependent processes, such as excitability, neurotransmitter
release, and gene expression. The activation of presynaptic neurons
leads to the release of neurotransmitters into the synaptic cleft via a
Ca2+-dependent process. The released neurotransmitters, in turn,
activate receptors in the PM of subsequent neurons, thus initiating
signal transmission. In postsynaptic neurons, the activation of neurotrans-
mitter receptors results in the generation of Ca2+ signals that trigger
responses that are speciﬁc to the type of receptor (reviewed in [8]). The
subsequent readout of Ca2+ signals employs Ca2+ binding proteinopean symposium on calcium.
ki).
. This is an open access article undersensors and downstream signaling proteins that transmit the Ca2+ signal
to cellular effectors. This allows the generation of various Ca2+ signals
with distinct spatial and temporal dimensions, amplitude, frequency
(in the case of oscillations), and localization (reviewed in [9,10]). In
addition to the mechanisms that activate neuronal pathways,
Ca2+ homeostasis comprises mechanisms that turn off Ca2+ signals
(reviewed in [10,11]).
Various Ca2+-permeable channels are present in the PM of neurons
(reviewed in [12]). These can be roughly divided into voltage-operated
Ca2+ channels (VOCCs), store-operated Ca2+ channels (SOCCs),
receptor-activated Ca2+ channels (RACCs) such as glutamate receptors
(e.g., N-methyl-D-aspartate [NMDA]) in hippocampal CA1 synapses;
[13], and transient receptor potential canonical channels (TRPCs;
[14–17]). The transient receptor potential (Trp) gene family encodes in-
tegralmembrane proteins that function as ion channels. These channels
are expressed from yeast to vertebrates and ubiquitously throughout
the body of mammals. Only few TRP channels are highly Ca2+ selective,
most are non-selective cation channels. TRP channels can be activated
by diverse intra- and extracellular stimuli that are either of physical
(temperature, osmotic pressure, mechanical stress) or chemical nature
(pH, pO2, reactive oxygen species, neurotransmitters, growth factors
and cytokines, environmental factors). The channels are involved in di-
verse physiological processes, and based on amino acid sequence ho-
mology, mode of activation and function they can be divided into
seven subfamilies: TRPC, TRPV, TRPM, TRPP, TRPML, TRPA and TRPN
(reviewed in [18]).
The ER also participates in the generation of Ca2+ signals by releasing
Ca2+ via inositol-1,4,5-triphosphate (IP3) receptors (IP3Rs; reviewed in
[19–21]) and ryanodine receptors (RyRs; [22]; reviewed in [23]) and
through passive leakage [24–26]. Both types of ER receptors that arethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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neurotransmitter-gated RACCs or VOCCs (reviewed in [27]).
The clearance of Ca2+ from the neuronal cytoplasm is attributable to
the function of Ca2+ pumps, exchangers (e.g., the Na+/Ca2+ exchanger;
[28], themitochondrial Ca2+ uniporter [29–32]), and Ca2+ binding pro-
teins, such as calbindin D-28k, calretinin, and parvalbumin [8,33–35].
The storage capacity of the ER is limited, and Ca2+ release must be
followed by Ca2+ replenishment. This is performed by Ca2+ reuptake
pumps (i.e., SERCAs [sarco-endoplasmic reticulum Ca2+-adenosine
triphosphatases (ATPases)]; reviewed in [36–39]). The mechanism of
subsequent Ca2+ entry from the environment is referred to as
capacitative Ca2+ entry (CCE) or store-operated Ca2+ entry (SOCE).
The reﬁlling of Ca2+ in the ER occurs by pumping Ca2+ via SERCAs.
Calcium then enters the cell through SOCCs located in the PM (reviewed
in [40]). The identity of SOCCs and coupling between their opening and
ER Ca2+ stores remained unidentiﬁed until the discovery of theOrai and
stromal interaction molecule (STIM) proteins.
In this review, we evaluate data on STIM and Orai proteins in neu-
rons to address the issue of whether SOCE in neurons is used only to re-
ﬁll Ca2+ in the ER or whether Ca2+ that enters the neuronal cell during
SOCE also performs signaling functions. If the latter, then what type of
function and through which pathways? The issue of the function of
SOCE in neurons may sound simply academic, but resolving this issue
has important implications for identifying new drug targets for the
treatment of brain diseases. Evidence indicates that in such neurode-
generative diseases as Alzheimer's disease and Huntington's diseases,
Ca2+ homeostasis and SOCE components become dysregulated
(reviewed in [4,8]). Thus, different targets and strategiesmight be iden-
tiﬁed for the potential treatment of these diseases (reviewed in [41]).
2. Store-operated Ca2+ entry before the discovery of STIM and Orai
Store-operated Ca2+ entry in non-excitable cells is a ubiquitous pro-
cess (reviewed in [42,43]). It was earlier referred to as CCE [44] and de-
scribed as an increase in Ca2+ inﬂux across the PM when the ER Ca2+
pool was emptied by an agonist [44,45]. The proof that extracellular
Ca2+ ions enter the cell to reﬁll the pool was provided by the use of
thapsigargin, which is a noncompetitive SERCA inhibitor derived from
Thapsia garganica [46]. The use of thapsigargin provided evidence that
the ﬁlling status of the intracellular store was responsible for Ca2+ in-
ﬂux via PM channels (reviewed in [47]).
The role of SOCE is well understood in various non-excitable cells,
and its molecular mechanism has been recently described in several re-
views [48,49]. Themechanism is based on the interaction between STIM
proteins (STIM1 and STIM2) that sense Ca2+ levels in the ER and Ca2+
channels in the PM, such as Orai (Orai1, Orai2, Orai3) (reviewed in
[50,51]). Originally STIM was discovered as a stromal cell-surface
interacting protein [52], reviewed in [53]. Reports indicate that SOCE
is also present in excitable cells, such as smooth muscle cells [54],
cardiac muscle cells [55,56], skeletal muscle cells [57–59], and neuronal
cells [60,61]. However, the physiological role of SOCE in excitable cells
remains unclear [55,62] and has even been challenged [63]. On the
other hand, P2Y receptor-induced signaling pathways, which play an
important role in the proper development of neuromuscular junctions,
depend on SOCE [64,65].
3. Store-operated Ca2+ entry in neurons after the discovery of STIM
and Orai
Convincing results indicated the existence of SOCE in the nervous
system (reviewed in [66,67]), but the mechanism of SOCE was un-
known. To determine whether it is similar to SOCE in non-excitable
cells, it was necessary to demonstrate that STIM and Orai proteins are
expressed in neuronal cells and are operational. Studies by [68] and
our group showed that STIM1 is present in neuronal cells in the brain
[69,70], together with Orai2 [71]. More information was subsequentlyobtained about the neuronal expression of STIM1, STIM2, and three
Orai proteins and their involvement in SOCE, indicating that this mech-
anism does in fact operate in these cells.
Growing evidence indicates substantial diversity among theproteins
that are engaged in SOCE. Several sets of PM channels, such as Ca2+
release-activated channels [CRACs] and TRPC mediate this process and
two types of Ca2+ sensors STIM1 and STIM2. CRACs are composed of
Orai protein subunits, and TRPC channels are homo and heteromeric
forms of TRPC proteins. Both types of channels, Orai and TRPC, are
gated by the STIM1 protein, although it is managed by different mecha-
nisms [72]; reviewed in [73,74]. TRPCs can be activated by PLC-derived
signals, such as DAG, independently of Ca2+ store depletion and/or in a
coordinated manner together with store-operated Orai channels
(reviewed in [75]). STIM1 associates with TRPCs through electrostatic
interactions. However, some of the channels of the TRPC family can
also operatewithout STIM1binding. The dual function of these channels
appears to depend on stoichiometry (i.e., the STIM1/TRPC channel ratio;
[76,77]). In many types of cells but not neurons, the activity of TRPCs
after store depletion appears to also be Orai1-dependent [73]. We as-
sume that STIMs, Orais, and some TRPC proteins are engaged in neurons
in SOCE and contribute to neuronal processes (Fig. 1). If so, then they
can also be involved in the etiology of some neurodegenerative diseases
(reviewed in [78]).
The SOCE response was detected in neurons and neuroglial cells
[69,79,80]. Although the major Ca2+ entry pathway in neuronal
cells occurs through voltage-operated Ca2+ inﬂux, recent reports
suggest that SOCE constitutes a crucial source of Ca2+ when neurons
are at rest [48,81]. Calcium microdomains were shown to be created
through VOCCs in neurons (reviewed in [82,83]). Calcium microdo-
mains may also be created through SOCE (reviewed in [84]).
The selectivity by which Ca2+ activates downstream pathways is
encoded by the oscillatory amplitude and frequency and spatial proﬁle
of Ca2+ signaling (reviewed in [83,85]). Different agonists can induce
versatile Ca2+ oscillation patterns (reviewed in [86,87]). In rat basophil
leukemia (RBL) cells, the stimulation of cysteinyl leukotriene type I
(cysLT1) or FCεRI receptors generates unique Ca2+ oscillation patterns
and gene expression through the activation of different STIM proteins
[88]. Agonist-induced Ca2+ entry with Orai1 or TRPC1 evokes different
patterns of Ca2+ signaling that activate distinct Ca2+-dependent gene
expression pathways. Orai1-mediated Ca2+ oscillations appear to efﬁ-
ciently induce the nuclear translocation of nuclear factor of activated
T-cells (NFATs), whereas Ca2+ entry via TRPC1 primarily regulates nu-
clear factor κB (NF-κB)-mediated gene expression [89].
4. Store-operated Ca2+ entry in polarized cells
Neurons are highly specialized cells with temporally and spatially
separated Ca2+ responses. They are a classic example of polarized cells
with long thin axons, a soma, and diverse forms of dendritic trees that
are specialized to receive and process excitatory synaptic inputs. This
neuronal polarity enables the directional ﬂow of information that is
required for communication between neurons or with effector cells.
Secretory epithelial cells, such as salivary acinar gland cells, are also po-
larized. Sustained ﬂuid secretion depends on the Ca2+ inﬂux pathway
that is mediated by SOCE (as reviewed in [90]). Neurotransmitter-
generated Ca2+ signals in exocrine gland cells are crucial for the regula-
tion of their secretory functions. The upregulation of ﬂuid secretion
in salivary glands is coordinated by autonomic sympathetic and
parasympathetic stimuli. Major receptors associated with salivary
gland ﬂuid secretion are G-protein-coupled receptors (GPCRs) such
as muscarinic M1 and M3, α-adrenergic receptors (e.g., α1A), and
some purinergic receptors. GPCR stimulation leads to the G-protein-
mediated activation of phospholipase C (PLC)-dependent pathways
(reviewed in [91]).
Distinct patterns of plasmalemmal channel localization involved in
SOCEwere revealed by immunostaining. TRPC1 is localized in the lateral
Fig. 1. Potential mechanism of Ca2+ inﬂuxmediated by STIM1 in neurons. After ER Ca2+ depletion STIM1 oligomerizes in ER and translocates toward PMwhere it activates SOCE. STIM1–
Orai1 complexes mediate Ca2+-selective and non-voltage-gated current (ICRAC), whereas STIM1–Orai1/TRPC and/or STIM1–TRPC complexes can mediate Ca2+-selective/nonselective
store-operated currents (Isoc); G protein-coupled receptors (GPCRs), phospholipase C (PLC), phosphatidylinositol 4,5-bisphosphate (PIP2), 1,2-diacylglycerol (DAG), inositol
trisphosphate (IP3), endoplasmic reticulum Ca2+-ATPase (SERCA), inositol trisphosphate receptor (IP3R), voltage-operated calcium channels (VOCCs), transient receptor potential cation
channels (TRPCs), Ca2+ release-activated Ca2+ channel protein 1 (Orai1), and stromal interaction molecule 1 (STIM1).
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calized in the lateral membrane toward the luminal side. STIM1 has dif-
fuse localization in these cells before stimulation; after agonist
stimulation, however, it moves to the lateral and basal regions of the
cells and strongly co-localizes in the lateral membrane region with
both channels. In the basal region, it co-localizes only with TRPC1 [92].
Thus, distinct localization of Orai1 and TRPC1 implicates compartmen-
talization of Ca2+ inﬂux (reviewed in [91]).
Similar patterns of STIM1, Orai1, andTRPC1distributionwere shown
to exist in pancreatic acinar cells, which are also highly polarized cells.
Orai1 is predominantly localized in the apical pole of the lateral mem-
brane and tight junctions where it co-localizes with tight junction pro-
tein ZO1. In resting cells, STIM1 is more diffuse, with intense staining
in the basal pole. Following stimulation, STIM1 is recruited to the lateral
and apical side. TRPC1 is expressed in both the apical and basolateral re-
gions of the PM. Stimulation by carbachol in the presence of mycotoxin
cyclopiazonic acid (CPA), an inhibitor of Ca2+-dependent ATPases,
enhanced the co-immunoprecipitation of STIM1 with Orai1 or IP3Rs
and the co-immunoprecipitation of STIM1 with TRPC1. This interaction
was diminished by 2-aminoethoxydiphenyl borate (2-APB), a SOCE
inhibitor [93].
Taking into account distinct distribution of STIM1, Orai1 and TRPC1
in epithelial secretory cells one can address several issues: (1) is this a
unique feature of these cells or a more general rule for all polarized
cells, including neurons, (2) whether STIMs and Orais are involved
only in SOCE and (3) whether the SOCE response in the soma has the
same function as the SOCE response in dendritic spines? Our group
showed that the interaction between endogenous STIM2 and Orai1
under low extracellular Ca2+ conditions is increased in cortical neurons
and that the majority of their complexes are detected in the soma [94].
This is the location of the rough endoplasmic reticulum (RER). Because
of the size of ribosomes, the RER does not permit direct contact between
STIM and Orai proteins. However, the ribosome-free extension of the
RER allows this organelle to form close junctions with the basolateral
PM in pancreatic acinar cells. The overexpression of STIM1-YFP protein
led to a two-fold increase in the density of ribosome-free terminals,
demonstrating the role of STIM1 in the formation of ER–PM junc-
tions [95]. This suggests that the RER, which is engaged in protein
synthesis, folding, and transport might be employed in SOCE. Thus,
an interesting line of investigation would be to explore whether
Orai-mediated Ca2+ entry is involved in the regulation of protein
synthesis in the RER.5. SOCE in transcription factor signaling
Substantial evidence has been provided in many types of cells that
proteins that are involved in SOCE, such as STIM and Orai, are engaged
in various signaling pathways that play crucial roles in the regulation
of cellular physiology and pathophysiology (reviewed in [96]). In addi-
tion to participating in calcium currents (Icrac, Isoc, Iarc) these proteins
have other functions. For instance, STIMs are involved in cell interaction
[52], andOrais in the secretory pathwayCa2+-ATPase-2 (SPCa2) [97]. In
many animal models, including studies using knockouts of STIM or Orai
genes, it was not unequivocally demonstrated that a particular result or
phenotype is in fact due to the loss of SOCE.
One of themost studied Ca2+-dependent signaling pathwayswhere
the SOCE response iswell documented is the Ca2+–calmodulin–calcine-
urin–NFAT pathway (reviewed in [98]). The stimulation of T cell recep-
tors (TCRs) leads to the activation of PLCγ1. Among the products of
PLCγ1 enzymatic activity are IP3 and diacylglycerol (DAG). IP3 binds to
the IP3 receptor (IP3R) on the ER membrane, releasing Ca2+ from the
ER into the cytoplasm. Depletion of the ER leads to the activation of
CRAC channels on the PM, which are composed of Orai proteins. Upon
the increase in Ca2+ inﬂux via CRACs, calmodulin binds Ca2+ and
forms a complex with the protein phosphatase calcineurin. This
complex dephosphorylates cytoplasmic NFAT and triggers NFAT mi-
gration into the nucleus (reviewed in [99]). Nuclear NFAT activates
gene transcription that is involved in many processes, including
cell proliferation, cytokine production, growth arrest, and cell death
(reviewed in [100]).
NFAT-dependent gene expression is known to be essential for the
development and function of the nervous system. NFAT-luciferase
transgenic mice were shown to exhibit much higher NFAT transcrip-
tional activity in the brain than in most other tissues [101]. The NFAT
signaling pathway is an important cascade in guided axonal growth
during neuronal development and the integration of synaptic plasticity
(reviewed in [102]). Sensory axon projections and commissural axon
growth were impaired in NFATc2, NFATc3, and NFATc4 triple-mutant
mice [103]. The response of axonal growth cones to neutrophin stimu-
lation ismediated by the calcineurin/NFAT cascade. Spinal cord explants
from these triple-mutantmice exhibited dramatic impairment in axonal
growth upon netrin-1 treatment compared with wildtype mice [103].
The NFAT signaling pathway is also known to be activated in neurons
upon Ca2+ inﬂux, which is mediated by L-type Ca2+ channels and
NMDA receptors [104]. The calcineurin-dependent expression of IP3Rs
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depolarization [104].
A recent study showed that SOCE regulates calcineurin/NFAT-
mediated gene expression and the proliferation of neural stem/progen-
itor cells (NPCs; [105]). Thapsigargin treatment of NPCs that were
derived from embryonic, neonatal, and adult mice induced a prominent
SOCE response via STIM1–Orai1 interactions. No difference was found
in the amplitude of SOCE between embryonic and adult NPCs, suggest-
ing that this Ca2+ entry mechanism is conserved throughout develop-
ment. The pharmacological proﬁle of SOCE in NPCs is characteristic of
CRACs [105]. This was conﬁrmed by the suppression or complete loss
of SOCE in embryonic NPCs that were derived from mice that lacked
either functional STIM1 or Orai1. However, in NPCs from adult Orai1
knockout mice, small residual Ca2+ inﬂux was observed after
thapsigargin treatment followed by extracellular Ca2+ re-addition.
This response was sensitive to a low concentration of La3+, suggesting
the involvement of other types of channels. It was determined that
epidermal growth factor (EGF), muscarine receptor agonist such as
acetylcholine (Ach) and metabotropic glutamate receptor (mGluR) ag-
onist, such as L-glutamate, are strong activators of SOCE in NPCs [105].
Moreover, this activation of SOCE led to high stimulation of NFAT-
mediated gene expression, which was affected by the SOC channel in-
hibitors 2-APB, SKF96365, and BTP-2 (Table 1). NFAT activation was
also completely lost in NPCs that were obtained from Orai1R93W/
R93W knock-in mice, which contain a loss-of-function R93Wmutation.
The regulated activity of transcription factors by neuronal activity
associated with membrane depolarization and Ca2+ signaling plays an
important role in the development and function of the central nervous
system. Sp4 transcriptional factor is highly expressed in neurons [106]
and regulated by Ca2+, which likely occurs via Ca2+ from SOCE [81].
Hypomorphic mice with reduced Sp4 expression exhibit impairments
in spatial learningmemory and synaptic plasticity. This might be associ-
ated with perturbations in dendrite patterning and contribute to the
pathophysiology of several neuropsychiatric disorders [107–110].
Under hyperpolarizing (5 mM KCl) conditions, SP4 was shown to be
polyubiquitinated and degraded by the proteasome in cerebellar
granule neurons (CGNs; [111]). In contrast, depolarizing conditions
(65 mMKCl), which stimulate neuronal activity, signiﬁcantly increased
the abundance of Sp4. In both cases, the mRNA level of Sp4 was un-
changed [81]. Furthermore, treatment with the SOCE inhibitors
SKF96365 and 2-ABP increased Sp4 abundance under depolarizing con-
ditions and completely blocked the reduction of Sp4 in CGNsunder rest-
ing conditions. These changes also occurred without changes in mRNA
levels. SKF96365 treatment prevented the polyubiquitination and deg-
radation of Sp4 in resting CGNs (5 mM KCl). Under these conditions,Table 1
Pharmacological agents modulating SOCE.
Agent SOCE
2-ABP (2-aminoethoxydiphenyl borate) Transient potentiation at low
concentration (~5 μM)
Inhibition at high concentration
(~50 μM)
SKF96365 (less speciﬁc to Ca2+ channels than 2-ABP) Inhibition
Thapsigargin Potentiation
CPA Potentiation
ML-9 Inhibition
Lanthanides Inhibition
BTP 2 3,5-bis(triﬂuoromethyl)pyrazole Inhibitionsustained Ca2+ inﬂux occurred in CGNs and was prevented by
SKF96365. The number of STIM1/Orai1/2 puncta was high in resting
neuronswith 5mMKCl application, moderate with 25mMKCl applica-
tion, and very low in depolarized neurons with 65 mM KCl application.
Altogether, these data indicate that SOCE in resting neurons may regu-
late Sp4-dependent transcription, which is consistent with the observa-
tion that a signiﬁcant reduction of Sp4 degradation occurs upon the
suppression of STIM1 levels [81].
6. Store-operated Ca2+ entry in guided axonal growth
Guided axonal growth and regeneration depend on the spatial and
temporal regulation of Ca2+ signals (reviewed in [112]). This is a key
component of the downstream signaling pathway that enables the
proper navigation of axons through a complex environment to reach
speciﬁc targets to form neuronal connections. The precise mechanism
by which this regulation in neuronal growth cones is coordinated in re-
sponse to guidance cues (e.g., netrins, semaphorins, and ephrins) is
unknown. The Ca2+ dependent growth cone responses to netrin-1
and brain-derived neurotrophic factor (BDNF) are mediated by
Ca2+-calmodulin dependent protein kinase II, and calcineurin and
can be modulated by cAMP pathways [113], reviewed in [112].
Semaphorin-3a signaling depends on cyclic guanosinemonophosphate
(cGMP) and Ca2+ inﬂux mediated by cyclic nucleotide-gated Ca2+
channels [114,115]. TRPC channels are involved in BDNF-mediated
nerve growth cone guidance in cultured cerebellar granule cells. The
pharmacological inhibition of TRPC3 channels or downregulation of its
expression using siRNA disrupted BDNF-mediated elevations in Ca2+
and growth cone turning [116].
Accumulating evidence demonstrates the contribution of STIM, Orai,
and TRPC proteins in neuronal growth cone and axon pathﬁnding, but
the mechanisms of their activity are unknown. Although their primary
function is associated with SOCE activation, data suggest other possibil-
ities, such as the involvement of STIM1 in cAMP signaling, ERmodeling,
and cytoskeleton reconstruction [117–119]; reviewed in [120,121].
Homer1 scaffolding protein in dorsal root ganglion (DRG) sensory
neurons was shown to facilitate signaling at the dendritic postsynaptic
density [122]. This occurred through the coupling of extracellular
receptors, such as mGluRs and TRPC family channels, to intracellular
receptors, such as IP3Rs. Isolated DRG neuronal growth cones turned to-
ward micro-gradients of BDNF and netrin-1 and were repelled by
semaphorin-3a. Homer1 knockdown had no effect on the growth cone
response to semaphorin-3a treatment and dramatically reversed
attraction to repulsion in response to BDNF and netrin-1. Moreover,
the BDNF-induced elevation of Ca2+ inﬂux was abolished in growthMechanism References
Initially described as an inhibitor of IP3R [228]
Modulator of STIM1 mediated Ca2+ inﬂux Reviewed in [74]
Inhibitor of transient receptor potential canonical
(TRPC) channels
[229]
Complex effect on Orai3 channels [230,231]
Activator of transient receptor potential vanilloid
(TRPV1, 2, 3)
Reviewed in [232]
Inhibitor of STIM1-mediated Ca2+ inﬂux Reviewed in [233]
Inhibitor of TRPC channels Reviewed in [234]
Inhibitor of voltage operated Ca2+ channels (VOCCs) [235]
Inhibitor of SERCA pump Reviewed in [47]
Inhibitor of SERCA pump [236]
Inhibitor of STIM1-mediated Ca2+ inﬂux Reviewed in [237]
Inhibitor of CRAC channels at low nM concentrations Reviewed in [238]
Inhibitor of TRPC and (VOCCs) at μM concentration Reviewed in [237]
Inhibitor of CRAC channels Reviewed in [237]
Inhibitor of debrin-actin reorganizing protein [239]
Inhibitor of TRPC3, TRPC5 [240]
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by SOCC inhibitors. Immunolocalization studies revealed a close
association between Homer1 and TRPC1 and STIM1 in functionally
relevant areas of growth cones, suggesting that the TRPC, Homer, and
STIM1 complex might be crucial for proper axon guidance [122].
Store-operated Ca2+ entry mediated by STIM1 and Orai1/Orai2 was
shown to be necessary for growth cone turning responses to extracellu-
lar guidance cues, such as BDNF and semaphorin-3a [123]. Changes
were observed in themorphology of growth cones, which exhibited dif-
ferent patterns of STIM1–Orai1/2 immunoreactivity. Themajority of the
growth cones displayed diffuse STIM1 and Orai1/2 immunoreactivity,
which was very narrow and did not spread, whereas growth cones
that displayed a punctate pattern of STIM1–Orai complexes presented
spreading lamellipodia. STIM1 knockdown caused a reduction of the
BDNF-induced elevation of Ca2+ inﬂux and changed the growth cones
response from attraction to repulsion after BDNF treatment, with no re-
sponse to semaphorin-3a exposure. Moreover, in the semaphorin-3a
collapse assay, growth cones that had reduced STIM1 expression exhib-
ited only minor suppression of spreading lamellipodial morphology
compared with controls. These characteristics were sustained even in
Ca2+-free medium [123].
Growth coneswere shown to require STIM1 and TRPC1 for attractive
guidance responses [124]. TRPC1 knockdown by morpholino or the
overexpression of dominant-negative STIM1 (STIM1-DN) abolished
the detection of SOCE in spinal neurons. The overexpression of STIM1-
DN also disrupted the sustained Ca2+ elevation in neuronal growth
cones in response to netrin-1. Localized and spontaneous Ca2+ tran-
sients in ﬁlopodia were shown to be affected by the inhibition of
STIM1 and TRPC1 function. This might indicate that STIM1- and
TRPC1-dependent SOCE is essential for ﬁlopodial Ca2+ entry and the
maintenance of oscillatory ﬁlopodial Ca2+ transient patterns. The inci-
dence and frequency of ﬁlopodial Ca2+ entry in response to netrin-1
were also impaired by alterations in STIM1 and TRPC1 expression. The
authors determined that a large portion of Ca2+ entry sites was located
at the ﬁlopodial tip, suggesting that this is a primary site of SOCE-
mediated Ca2+ entry in nerve growth cones [124]. The observation
that STIM1-DN overexpression completely abolished netrin-1-induced
attraction, resulting in repulsion, is consistent with previous studies
that reported that TRPC1 knockdown impaired netrin-1-induced attrac-
tive growth cone turning responses [125,126]. Altogether, these results
suggest that proteins that are involved in SOCE may mediate axon
pathﬁnding.
7. Store-operated Ca2+ entry in synaptic plasticity
Baba and coworkers showed that SOC channel inhibitors, such as
2-APB and SKF96365, attenuated tetanus-induced dendritic Ca2+ accu-
mulation and long-term potentiation (LTP) at Schaffer collateral-CA1
synapses in the hippocampus [127]. This report, together with other
results, demonstrated impairments in spontaneous Ca2+ transients in
synaptic boutons by blocking SOCE with La3+ [60] and suggested that
SOCE may play a role in synaptic plasticity. Useful insights into the
role of intracellular stores in neuronal function and plasticity were
suggested by Narayanan and coworkers [128]. It was demonstrated
that intracellular calcium store depletion in rat hippocampal neurons
induces a perisomatic increase in the density of functional h channels
(hyperpolarization-activated cyclic nucleotide-gated ion channels,
HCN) mediated by Ca2+ elevation through the activation of InsP3Rs
and SOC channels [128]. In the mammalian central nervous system,
slow synaptic transmission involves the activation ofmGluRs (reviewed
in [129]). These are G-protein-coupled neurotransmitter receptors that
are found in the presynaptic and postsynaptic densities of synapses
(reviewed in [130]). They are implicated in many forms of neural
plasticity, including hippocampal LTP [131–133], long-term depression
(LTD; [134,135]), and associative learning [136,137]. TRPC1 was
shown to be physically associated with mGluR1 and engaged inmGluR1-evoked slow excitatory postsynaptic conductance in Purkinje
cells [138]. A subsequent report showed that TRPC3 is also important
for mGluR-dependent synaptic signaling in mouse cerebellar Purkinje
neurons [139]. A recent paper provided evidence that STIM1 is required
for store reﬁlling in resting Purkinje neurons and mGluR1-dependent
TRPC3 activation [140]. The authors showed that the absence of STIM1
strongly attenuated IP3R-dependent Ca2+ signals and mGluR1-
dependent synaptic potentials. Notably, TRPC3 channels have been
described as mediators of BDNF-mediated dendritic remodeling in
hippocampal CA1 pyramidal neurons [141]. BDNF plays a signiﬁcant
role inmodulating synaptic plasticity (reviewed in [142]) by enhancing
synaptic transmission at excitatory synapses and altering dendritic
architecture [143]. The role of interactions between STIM1 proteins
and TRPC channels is under vigorous investigation (reviewed in [73]).
Interesting data show that synaptopodin (SP) may interact with
SOCE machinery. Synaptopodin is an actin binding protein and marker
of the enigmatic spine apparatus [144]. This cellular structure is com-
posed of a stacked smooth ER [145]. Synaptopodin was shown to be es-
sential for the formation of this organellum. For example, it is absent in
SP-deﬁcient mice [146]. These mice show deﬁcits in synaptic plasticity
and spatial learning [147]. Upon treatment with kainic acid or tetanic
stimulation, the expression of SPwas increased in hippocampal neurons
[148,149]. Spines that contain SP generate a two-fold larger Ca2+ re-
sponse to ﬂash photolysis of caged glutamate than SP-negative spines.
This increase disappears with CPA treatment, indicating the involve-
ment of the ER [150]. Thus, SP is involved in the glutamate response
and appears to be associated with Ca2+ stores [150]. Synaptopodin
tends to accumulate in large-head spines [150,151]. A recent study
demonstrated that STIM1 preferentially localized in spines that
contained SP in cultured hippocampal neurons that were derived from
SP knockout mice and transfected with a SP-green ﬂuorescent protein
(GFP) expression vector [119]. This association was especially promi-
nent in mushroom spines. Consistent with this observation, a loss of
STIM1 puncta was observed in mushroom spines without SP. Orai1 lo-
calization in this particular type of spine also appeared to be SP-
dependent. These results indicate that SP may interact with SOCE in
synaptic plasticity [119].
Non-receptor protein tyrosine kinases (PTKs), such as the Src family,
are highly expressed in the brain. Their functions are postulated to be
associated with the regulation of neuronal plasticity (reviewed in
[152]), behavior [153], and cognitive deﬁcits in schizophrenia [154].
Protein tyrosine kinase and protein tyrosine phosphatase (PTP) were
shown to modulate Ca2+ responses mediated by NMDA receptors
(NMDARs; [154]; reviewed in [155,156]) and voltage-gated Ca2+ chan-
nels (reviewed in [157]). In pancreatic acinar AR42J cells and HEK293
cells, the SOCE response was reported to bemodulated by protein tyro-
sine phosphatase 1B (PTP1B). Its overexpression triggered the inhibi-
tion of SOCE responses, whereas pharmacological inhibition led to an
increase in SOCE [158]. Furthermore, SOCE induced an increase in reac-
tive oxygen species and subsequent inhibition of PTP1B [159]. These
data indicate that PTP1B plays a crucial role in the regulation of SOCE.
Upon CPA treatment, Ca2+ inﬂux in cultured hippocampal neurons
that were derived from PTP1B knockout mice was higher than in cells
from wildtype animals. This indicates that this type of SOCE regulation
is also present in neurons. Administration of the PTK inhibitor Ag126
suppressed SOCE in both wildtype and PTP1B knockout neurons. The
global level of tyrosine phosphorylation was much higher in PTP1B
knockout hippocampal neurons than in wildtype cells. This effect ap-
peared to be at least partially mediated by the modulation of Src ki-
nase activity [160]. Administration of sodium orthovanadate, an
inhibitor of PTP, upregulated PTK activity in neonatal rat hippocam-
pal neurons, which not only induced SOCE but also modulated
NMDA-induced neuronal excitability. The authors suggested that
the tyrosine-based phospho-regulation of SOCE might be involved
in the phospho-tyrosine-dependent regulation of NMDAR-induced
signaling pathways [161].
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The majority of Ca2+ inﬂux in neurons occurs via VOCCs that are ac-
tivated by depolarization and are essential for synaptic vesicle release,
contraction, and electrical excitability (reviewed in [162]). One subtype
of VOCCs, Cav1.2 channels, is ubiquitously expressed in neuronal, cardi-
ac, and smooth muscle cells (reviewed in [163]). STIM1 directly sup-
pressed the depolarization-induced opening of voltage-gated Cav1.2
channels [164]. The treatment of cultured rat cortical neurons with
1 μM thapsigargin led to an ~20% decrease in the initial slope of the
Ca2+ rise, suggesting that store depletion inhibited the conductance
by VOCCs. A deeper analysis of this phenomenon revealed that STIM1
altered the surface expression of Cav1.2 by internalizing the channels.
The authors provided a mechanism by which STIM1 was recruited to
Cav1.2 channels after store depletion and triggered Cav1.2 internaliza-
tion, leading to its complete loss of function. They also suggested that
STIM1 acts as a switch that promotes Ca2+ entry through Orai channels
and inhibits Ca2+ entry through Cav1.2. This regulation of Cav1.2 could
be important after the activation of PLC-coupled receptors, such as do-
pamine D2 receptors [165]; reviewed in [166]. A similar observation of
STIM1-dependent inactivation of VOCCs in vascular smooth muscle
cells was made by another research group [167]. These authors found
that STIM1 did not require Orai channels for the attenuation of Cav1.2
channel activity. However, they found that Orai may enhance STIM1 re-
cruitment to the proximity of Cav1.2 channels by effectively trapping
STIM1 in puncta. STIM1 has also been shown to interact with both
types of channels through the short STIM–Orai activating region. The re-
sults of both research groups show that store depletion activates SOCCs
and inhibits VOCCs, prompting Moreno and Vaca to introduce a novel
term: store-inhibited channels (SICs; [168]). They postulated that the
ﬁrst member of this family is an L-type VOCC. STIM1 also inhibits
T-type Ca2+ channels (Cav3.1) in cardiomyocyte-derived HL-1 cells.
Co-immunoprecipitation experiments revealed that STIM1 is associated
with Cav3.1 channels in HL-1 cells and reduces its activity to prevent
excessive Ca2+ entry [169]. Harraz and Altier speculated that the
STIM1-dependent modulation of Cav3.1 could be involved in modulat-
ing the rhythmicity and excitability of cardiac pacemaker cells and
may be involved in pathological cardiac events (e.g., arrhythmias;
[170]). One unresolved issue is the role of the long isoform of STIM1
(STIM1L), which is predominantly expressed in muscle cells and the
brain [171–173] (Fig. 2). STIM1 appears to be a multifunctional protein
in excitable cells (see Fig. 1). After store depletion, it activates CRACs
and concurrently inhibits some VGCCs. The immunolocalization of
STIM1 in the mouse brain has been described [70,174,175].
9. Store independent function of STIM and Orai proteins in
non-neuronal cells
Arachidonate-regulated Ca2+ channels (ARCs) represent a member
of highly selective Ca2+ entry channels in various cell types, includingFig. 2.Molecular domains of human STIM1 protein. Comparison of structural features of STIM1,
hand (hEF), a sterile alphamotif (SAM),which helps initiate STIM1 oligomerization, a transmem
acidic inhibitory domain (ID), whichmediates fast Ca2+-dependent inactivation of Orai1, an act
main (TRIP) and a lysine-rich domain (K), which is responsible for phospholipid interaction atHeLa cells, COS cells, RBL cells, DT40 cells [176], and parotid and pancre-
atic acinar cells [177]. These channels, which are formed by a combina-
tion of Orai1 and Orai3 subunits [178], are activated by arachidonic acid
independently of ER Ca2+ depletion. They are also insensitive to inhibi-
tionwith 2-APB, unlike CRACs [176]. STIM1 plays a role in the regulation
of ARCs. The minor pool of STIM1 that resides at the PM (PM-STIM1) is
necessary for ARC activation in HEK293 cells [179]; reviewed in [180].
Leukotriene C4-regulated Ca2+ channels (LRCs) share many ARC-like
features, such as store independence and insensitivity to inhibition
with 2-APB. In vascular smooth muscle cells (VSMCs), the activation
of these channels by thrombin was shown to require STIM1, Orai1,
and Orai3 [181]. Zhang and coworkers showed that unlike ARCs in
HEK293 cells, the activation of LRCs in VSMCs by thrombin required
ER-STIM1. However, PM-STIM1 could support thrombin-activated
Ca2+ entry in these cells [182], suggesting a complex role for both
pools of STIM1, in which endoplasmic and plasmalemmal pools are in-
volved in the regulation of store-independent Orai1/Orai3 channels.
One may speculate whether similar store-independent activities of
STIM1, Orai1 and Orai3 exist in neurons.
10. Role of STIM2
STIM2 is a more sensitive Ca2 + sensor than its homolog STIM1.
STIM2 is characterized by slower activation kinetics and activated by
smaller depletion of the ER [183,184]. STIM2 is predominantly
expressed in mouse brain, with abundant expression in hippocampal
neurons [70,174,175]. STIM2-deﬁcient mice develop normally but
have a reduced life expectancy. Approximately 8 weeks after birth, sud-
den death is observed in homozygous mice (STIM2−/−). In the Morris
water maze (i.e., a standard test for hippocampus-dependent spatial
memory), STIM2−/− mice required a longer time to ﬁnd the hidden
platform, suggesting that STIM2 deﬁciency leads to cognitive impair-
ment [174]. In cultured neurons from STIM2−/− mice, the SOCE re-
sponse was reduced following CPA treatment. This reduction was
shown to be regulated by STIM2, with no contribution from STIM1 or
Orai1. In cultures of cortical neurons derived from STIM1−/− and
Orai1−/− mice, no changes were observed in the SOCE response in-
duced by stimulation with CPA followed by the replacement of 1 mM
ethylene glycol tetraacetic acid (EGTA) with 2 mM Ca2+ [174]. This ob-
servation may suggest that Orai2, the prominent expression of which
was observed in the brain, may mainly contribute to SOCE in neurons,
rather than Orai1 [71]; reviewed in [185]. In HEK293 and RBL cells,
the ability of Orai2 to form CRACs depends on the cell background
[71]. However, our research group used the Proximity Ligation Assay,
co-immunoprecipitation, and single-cell Ca2+ imaging and found that
endogenous STIM2 under low-Ca2+ extracellular conditions is associat-
ed with endogenous Orai1 in primary cortical neurons derived from rat
embryos [94]. These results are consistent with our previous studies of
ectopically expressed yellow ﬂuorescent protein (YFP)-STIM2 and
Orai1 in cortical neurons, in which the number of STIM2/Orai1 punctaSTIM1L: a signal peptide (SP), a canonical Ca2+ binding EF-handmotif (cEF), a hidden EF-
brane domain (TM), coiled-coil domains (CC1), a STIM1–Orai activating region (SOAR), an
in-binding domain (ABD), a proline/serine rich domain (PS), a microtubule interacting do-
the PM.
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difference was found between the number of YFP-STIM1/Orai1 and
YFP-STIM2/Orai1 puncta following thapsigargin treatment. The reduced
number of YFP-STIM2/Orai1 puncta was correlated with the suppres-
sion of Ca2+ entry after store depletion. The observation that neurons
that were transfected with YFP-STIM2/Orai1 showed a greater increase
in constitutive Ca2+ entry than YFP-STIM1/Orai suggests that STIM2 is
involved in the regulation of resting Ca2+ levels in neurons [175]. One
caveat should be considered regarding the activity of YFP-STIM2. The
construct contained the signaling peptide of STIM1 [183]. Thus, the lo-
calization of STIM2 in transfected neurons might not fully resemble
physiological conditions.
Under ischemic conditions, such as low glucose and lowpH, cultured
hippocampal neurons from STIM2−/−mice survived signiﬁcantly longer
comparedwith STIM1−/− andwildtypeneurons. In vivo STIM2deﬁcien-
cywas shown to protectmice from ischemic neuronal damage indepen-
dent of functional alterations within the hematopoietic system.
Histological analysis of the brains ofmice subjected to transient focal ce-
rebral ischemia revealed that infarcts in STIM2−/−mice were restricted
to the basal ganglia, whereas they extended to the neocortex in
wildtype mice. The authors suggested that STIM2 mediates neuronal
SOCE, and this pathway might play a pivotal role in hypoxia-induced
neuronal death [174].
In immortalized lymphocytes from patients with familial
Alzheimer's disease, STIM2 levels decreased, whereas STIM1 levels
remained unchanged [186]. Consistent with these observations, a re-
cent study found that the level of STIM2 protein was dramatically re-
duced in the hippocampus in PS1-M146V KI mice, a model of familial
Alzheimer's disease, and in cortical samples from sporadic Alzheimer's
disease patients [187]. These changes correlated well with Mini Mental
State Examination scores in Alzheimer's disease patients that indicated
the degree of dementia. The changes were also consistent with a reduc-
tion of the neuronal SOCE response in spines in PS1-M146V KI mice. In
hippocampal neurons derived from PS1-M146V KI mice, a signiﬁcant
reduction of the fraction of mushroom spines was detected, together
with an increase in the fraction of thin spines. The reduction of STIM2
also appeared to affect themorphology of dendritic spines in the hippo-
campus. STIM2 deletion in conditional knockout mice dramatically re-
duced the amplitude of synaptic SOCE and reduced CaMKII activity.
Consistent with these observations, immunolocalization analyses
showed that STIM2 was highly enriched in mushroom spines where it
co-localized with pCaMKII. The Cdc42/Rac1 pathway, one of the
downstream targets of CaMKII that is known to be involved in
actin cytoskeleton reorganization in spines, was affected in PS1-
M146V KI mice. Altogether, these data provided strong evidence
that STIM2 is a crucial regulator of the synaptic SOCE–CaMKII path-
way that is implicated in the maintenance of dendritic mushroom
spines [187].
An interesting study that may have signiﬁcant implications in our
understanding of how STIM2 operates in neurons was conducted with
HEK293 cells [188]. STIM2 was shown to exist in three distinct forms:
ER resident STIM2, cytosolic preSTIM2, and cytosolic SPF. SPF is an
~91-amino-acid short fragment of the STIM2 signaling peptide that is
cleaved by signal peptide peptidases. All three forms are the result of
STIM2's possessing a very long (101 amino acid), highly conserved sig-
naling peptide. PreSTIM2 is targeted to the inner leaﬂet of the PM,
whereas SPF is distributed in the cytosol (Fig. 3). PreSTIM2 can associate
with Orai1 in the PM in a store-independentmanner. The authors found
that the regulation of basal Ca2+ inﬂux by preSTIM2 regulated NFAT-
and NF-κB-dependent transcription, whereas SPF slightly increased
NF-κB-mediated transcription in a Ca2+-independent manner. Both
preSTIM2 and SPF might bind calmodulin in the presence of Ca2+, indi-
cating that they may regulate calmodulin-mediated processes. The au-
thors proposed a new model whereby basal Ca2+ and SOCE are
predominantly controlled by two distinct proteins, preSTIM2 and
STIM2 [188].11. SOCE in neurological disorders
Chronic increases in corticosteroid hormone levels in adult rats and
humans make hippocampal neurons more sensitive to various
neurological insults, which can lead to dendrite atrophy [189–191].
The chronic corticosterone treatment signiﬁcantly increased SOCE in
H19-7 cells, a cell-culturemodel of differentiating hippocampal neurons
[192]. As previously demonstrated by Wu and coworkers, H19-7 cells
undergo a dramatic increase in SOCEduring differentiation,which is de-
creased by TRPC1/3 knockdown [193]. Surprisingly, TRPC1 knockdown
did not block the enhancement of thapsigargin-stimulated Ca2+ entry
caused by corticosterone treatment. The electrophysiological data indi-
cated that in corticosterone-treated H19-7 differentiated neurons the
store-operated Ca2+ currents exhibit the classic shape of ICRAC. Consis-
tent with this observation the authors also reported a dramatic increase
in Orai1 immunostaining in corticosterone-treated cells compared with
untreated cells. The results suggest that chronic exposure to high levels
of stress hormones switched the SOCE response from the ISOC subtype to
the ICRAC subtype. The authors discussed the possible consequences of
upregulating ICRAC channels during periods of chronic stress and the im-
plications for hippocampal neurons and memory retention [192].
The dysregulation of Ca2+ signaling has been shown to be a major
factor in the development of pain behavior after peripheral nerve injury
[194,195]. In dorsal root ganglion (DRG) neurons painful nerve injury
disrupted Ca2+ levels in ER stores and decreased releasable Ca2+ from
the ER [196]. Furthermore, peripheral nerve injury diminished the
anatomical extent of the ER and reduced the expression of SERCA
[197]. Recently, the same group showed that Ca2+ inﬂux via SOCE
after spinal nerve injury is needed for the preservation of intracellular
levels of cytoplasmic and releasable pools of Ca2+ [80]. The expression
of STIM1 and Orai1 in the DRG neurons was conﬁrmed at both the
mRNA and protein levels. An increase in SOCE was observed after
thapsigargin treatment, which was affected by La3+ and 2-APB. In con-
trast, the inhibitor SKF96365 had no effect on Ca2+ inﬂux stimulated by
thapsigargin. SOCE was needed in the DRG neurons to replenish Ca2+
stores after a release event evoked by caffeine. The electrophysiological
analysis revealed that store-operated Ca2+ currents in the DRG neurons
exhibit the classic shape of the ICRAC subtype. After peripheral nerve
injury in rats by spinal nerve ligation (SNL; i.e., a standardmodel of neu-
ropathic pain), ampliﬁcation of the SOCE response was observed. An in-
crease in ICRAC currentswas also detected after SNL. However, themRNA
and protein levels of STIM1 and Orai1 were unaffected by SNL.
Moreover, in both cases, when store depletion was induced by
thapsigargin, no differences in the SOCE response or ICRAC currents
were observed between control and affected DRG neurons. These re-
sults suggest that nerve injury activates SOCE, but the intrinsic capacity
of SOCE remains unchanged. The level of cytoplasmic and stored Ca2+ in
resting sensory neurons was diminished by injury. In fact, the termina-
tion of SOCE by removing Ca2+ from the medium led to much higher
depression of Ca2+ levels in neurons after injury. This observation sug-
gests that SOCEmay play a compensatory role after injury. The upregu-
lation of SOCE in injured neurons appears to be particularly involved in
maintaining Ca2+ levels in the cytoplasm and stores [80].
Recently Xia and coworkers revealed that a novel Ca2+ signal medi-
ated by store operated Ca2+ entry is present in dorsal horn neurons and
may play an important role in pain transmission [198]. Previously this
group demonstrated that YM-58483 (BTP2), a potent SOC channel in-
hibitor, produces a strong central analgesic effect and prevents the de-
velopment of chronic pain in mice [199]. This group conﬁrmed the
functionality expression of protein involved in SOCE — STIM1, STIM2
and all three isoforms of Orais in dorsal horn neurons. Reduction of
STIM1 or STIM2 or Orai1 by knockdown using siRNA markedly
decreased SOCE as well as the basal cytosolic Ca2+ level in these cells.
It suggests that SOCE contributes in resting Ca2+ homeostasis.
Treatment with substance P (SP), neurotransmitter of pain processing
acting through the neurokinin 1 (NK1) receptors led to SOCE activation
Fig. 3.Molecular domains of STIM2 protein and its subcellular localization. A) Three forms of STIM2 protein: preSTIM2 localized in the cytosol and associated with PM, mature STIM2 lo-
calized in the ER, signal peptide fragment (SPF) localized in the cytosol. This is a result of productive or aborted translocation of nascent STIM2 polypeptides through the ER translocon; a
signal peptide (SP), a canonical EF-hand motif (cEF), a hidden EF-hand (hEF), a sterile alpha motif (SAM), a transmembrane domain (TM), coiled-coil domains (CC1), a STIM1–Orai acti-
vating region (SOAR), and a proline/histidine-rich domain (PH). Arrows indicate cleavage of SP by signal peptide peptidases. B) Both STIM1 and STIM2 are localized in the ER membrane
and sense Ca2+ level within the store. After ER depletion STIM proteins present in the ER oligomerize and translocate toward PM. STIM2 protein is activated by smaller changes in Ca2+
level within the ER. Both homologs could also be localized in PM, whereas STIM2 is localized in the cytosol.
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Altogether these results indicate that SOCE may modulate the Ca2+-
dependent pathological events related to chronic pain [198].
Parkinson's disease is one of the most common neurodegenerative
disorders. It is characterized by the selective loss of dopaminergic neu-
rons in the substantia nigra. The major symptoms involve motor dys-
function (reviewed in [200]). One of the mechanisms that affect the
survival of dopaminergic neurons in Parkinson's disease is associated
with dysregulation of Ca2+ levels, especially in the ER andmitochondria
[201]. One of the consequences of perturbing Ca2+ homeostasis is the
accumulation of unfolded/misfolded proteins in the ER lumen. To allevi-
ate ER stress and improve cell survival, the unfolded protein response
(UPR) is activated (reviewed in [202]). However, prolonged activation
of the UPR results in programmed cell death (reviewed in [203]). The
oxidative form of neurotoxin 1 (MPP+) induced the selective loss of
dopaminergic neurons in the substantia nigra, leading to the develop-
ment of a mouse model that mimics Parkinson's disease. In SH-SY5Y
neuroblastoma cells, C57/BL mice, and PC12 pheochromocytoma cells,
MPP+ treatment decreased the level of TRPC1 and consequently
increased neuronal death [204,205]. The loss of SOCE, which was
observed in SH-SY5Y cells upon MPP+ treatment, might be involved
in the induction of ER stress and initiation of the UPR [206]. Electrophys-
iological studies in SH-SY5Y cells revealed that store-operated currents
are mediated by ISOC channels and decrease with SKF96365 and MPP+
treatment. The interaction between STIM1 and TRPC1 is also reduced
with neurotoxin 1 treatment. In contrast, the association between
STIM1 and Orai1 was unaffected by MPP+ application, indicating that
TRPC1 is essential for SOCE in SH-SY5Y cells. A decrease in TRPC1expression was also observed in brain tissue derived from Parkinson's
disease patients and mouse primary dopaminergic neurons treated
with neurotoxin 1. In SH-SY5Y cells, the silencing of TRPC1 decreased
SOCE and Ca2+ levels in the ER and induced the UPR. Several UPR
markers, such as GRP78 and CHOP, were upregulated after the speciﬁc
suppression of TRPC1 but not TRPC3. Consistent with these data, upreg-
ulation of the UPR after TRPC1 or STIM1 silencing was associated with
the inhibition of protein translationmediated by increasing eIF2α phos-
phorylation. A similar observation was made in Trpc1−/−mice, which
exhibited greater activation of UPRmachinery compared with wildtype
mice. Altogether, these results indicate that the inhibition of SOCE due
to silencing of TRPC1 leads to the dysregulation of Ca2+ levels in the
ER and induces ER stress. The overexpression of TRPC1 but not Orai1
in SH-SY5Y cells restored SOCE and attenuatedMPP+-inducedER stress.
Moreover, MPP+ administration signiﬁcantly decreased AKT1 phos-
phorylationwithout affecting total AKT1 levels in SH-SY5Y cells, where-
in the relationship between AKT and neuroprotection is well
established [207]. Surprisingly, thapsigargin treatment in the absence
of external Ca2+ abolished AKT phosphorylation in SH-SY5Y cells, indi-
cating that SOCE plays a crucial role in this pro-survival pathway. This
effect was shown to be mediated by TRPC1. In contrast, BDNF expres-
sion was not enhanced by TRPC1 overexpression, although MPP+ de-
creased BDNF expression. Moreover, a signiﬁcant decrease in neuronal
survival was observed with MPP+ application in SH-SY5Y cells, which
was inhibited by TRPC1 overexpression. Furthermore, the suppression
of AKT1 abolished TRPC1-mediated neuroprotection against MPP+ in
SH-SY5Y cells. The results obtained in the Parkinson's disease mice
model in vivo were consistent with studies on SH-SY5Y neuroblastoma
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mammalian target of rapamycin (mTOR) in dopaminergic neurons,
which might induce neurodegeneration. TRPC1 overexpression in
mouse substantia nigra upon neurotoxin 1 administration signiﬁcantly
restored the activation of mTOR and its downstream targets. These re-
sults indicate that TRPC1-mediated SOCE in dopaminergic neurons is
necessary for the activation of AKT/mTOR-dependent neuroprotection.
Thus, TRPC1-dependent SOCE appears to be necessary for the mainte-
nance of Ca2+ levels in the ER. The suppression of its function activates
the UPR pathway, resulting in the depletion of AKT and consequently
leading to the neurodegeneration of dopaminergic neurons and
Parkinson's disease [206]. It is of interest that SOCE is dysregulated
also in several models of Huntington's disease [208–210].
12. SOCE components as therapeutic targets: conclusions and
future directions
Ca2+ dysregulation has been observed in a broad range of diseases
(reviewed in [211], including brain disorders [41,212–214]). The
complexity of Ca2+ homeostasis and signaling makes it difﬁcult to
understand the relationships between all of the factors involved.
Nevertheless, studying these processes is greatly important because of
the potential of using the acquired knowledge to identify new drug
targets and develop novel therapeutic strategies. In this article, we fo-
cused on SOCE, a mechanism with well-established signiﬁcance in
non-excitable cells, such as lymphocytes. Store-operated Ca2+ entry
has also been recognized as important for excitable cells, such as neu-
rons, indicating that SOCE has dual roles. One role is to reﬁll Ca2+ that
is released from the ER during cell activation, which initiates speciﬁc
signaling pathways. The other role is to in parallel trigger various
other signaling pathways.
Store-operated Ca2+ entry or its components are disturbed in many
brain diseases andmodels of these diseases (reviewed in [8]), including
Alzheimer's disease [41,215,216], Parkinson's disease [217], epilepsy
[218,219], and Huntington's disease [220]. In one hand, SOCE appears
to be neuroprotective (e.g. in Parkinson's disease) [206], while in
other situations such as for instance under ischemic conditions, neuro-
protection is achieved by blocking SOCE [174]. Dual form of SOCE action
should be taken under consideration while debating SOCE elements as
potential targets for new drugs. Nevertheless three classes of SOCE or
SOCE-responsive proteins are potential targets for new drugs. One
class is a group of Ca2+ sensors (STIM1, STIM2, and their isoforms)
that are located in different cellular compartments. The second class
consists of Ca2+ channels, which are either activated (Orais and TRPs)
or inhibited (voltage-operated channels) by STIMs. The third class con-
sists of proteins that sense Ca2+ entering the cell during SOCE and then
can activate speciﬁc pathways. If new drugs can successfully target
these proteins speciﬁcally, then theymight improve or correct dysregu-
lated Ca2+ homeostasis and signaling without major side effects. The
discovery, mechanisms, and biological activity of some chemical com-
pounds have been described [170,221–227]. The search for these
drugsmay contribute to thedevelopment of treatments for currently in-
curable diseases, such as Alzheimer's disease.
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